Sinopharm Current Affairs, GK & News

UAE launches Covid vaccine for children aged 3-17

United Arab Emirates (UAE) launched Covid-19 vaccines for children aged 3 to 17. Key Points UAE will administer China’s Sinopharm COVID-19 vaccine to children aged 3-17. This decision was taken after clinical trials and extensive evaluations. As per authorities, trial was monitored for immune response of 900 children. UAE is among world’s highest immunisation rates. ..

Month: 

Category: 

Topics: 

China’s vaccine makers sign COVAX agreements

Two major COVID-19 vaccine makers of China have signed agreements to provide 550 million doses to COVAX facility. Highlights Gavi announced to buy 110 million doses from Sinopharm and Sinovac between July and October 2021. It will buy 440 million more doses by mid-2022. These vaccines were approved by World Health Organization for emergency use. ..

Month: 

Category: 

Topics: 

Sinopharm Vaccine approved by WHO

The World Health Organisation recently approved the Emergency Use of Sinpharm vaccine. Recently, the WHO approved COVID-19 vaccines developed by AstraZeneca, Pfizer, BioNTech, Johnson and Johnson as well. The other popular Chinese Vaccine is sinovac. Sinopharm Vaccine Sinopharm vaccine was developed by China. This is the first time the WHO has given approval to a ..

Month: 

Category: 

Topics: 

Sinopharm Commences Phase III Trial of COVID 19 Vaccine in UAE

Chinese state-owned pharmaceutical company, Sinopharm, has started the first Phase III clinical trial of its inactivated COVID 19 vaccine in Abu Dhabi, UAE. The UAE health authorities have issued a permit for up to 15000 volunteers to take part in the trials. Highlights                                                                                                                                           The trials are being conducted as a result of the cooperation ..

Month: 

Category: 

Topics: